SGStephanie Gilbertson-White

Stephanie Gilbertson-White

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stephanie Gilbertson-White has a total of 210 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Empowering nursing excellence: How liberation capital can elevate innovative ideas

    by Rachel L. DiFazio, Sheridan Miyamoto, Stephanie Gilbertson-White, Dora L. Clayton-Jones, Kamila A. Alexander, Erica Liebermann, Amanda M. Emerson, Forgive Avorgbedor, Heather Nelson-Brantley, Luz Huntington-Moskos, et al.

  • Open Access

    Nurse leaders achieving equitable research and evidence translation into policy, practice, and products

    by Joan G. Carpenter, Kamila A. Alexander, Grace Campbell, Jin Jun, Jessica Keim-Malpass, Michelle L. Litchman, Sheridan Miyamoto, Heather Nelson-Brantley, Kimberly Powell, Susan Reinhard, et al.


  • Social Determinants of Health and Epigenetic Age Acceleration in Type 2 Diabetes: A Systematic Review

    by Chelsea Howland, Stephanie Gilbertson-White, Shaoshuai Chen, Young-Eun Cho

    Background: Individuals with type 2 diabetes (T2D) experience epigenetic age acceleration (EAA), as described by DNA methylation based epigenetic clocks. It is critical to examine relationships between social determinants of health (SDOH) and EAA in people living with T2D to understand mechanisms interconnecting social and biologic drivers of health disparities. The purpose of this systematic review was to describe the role of SDOH as factors influencing EAA in T2D. Methods: PubMed, CINAHL, and Embase were comprehensively searched. Research reports were independently screened and abstracted; quality was assessed using JBI checklists. The Healthy People 2030 SDOH Framework guided this study. Domains of SDOH were benchmarked against the framework to identify roles and gaps. Results: Of 25 included research reports which evaluated epigenetic aging in T2D, 64% describe at least one SDOH. SDOHs within education access and quality (44%), neighborhood and built environment (40%), and economic stability (36%) domains are the most well represented; however, the depth and breadth of conceptual understanding were limited. Concepts representative of SDOH including childhood low socioeconomic status and victimization, trauma, and lower education and income were positively associated with EAA in T2D. Discussion: While SDOH are increasingly included in studies of EAA in people with T2D, critical gaps in understanding the roles and relationships between SDOH and EAA were revealed. Findings support the need to move further than socioeconomic status to comprehensively explore SDOH domains influencing EAA in individuals living with T2D, which will provide a framework for identifying health inequities.


  • Predictors of Health Care Utilization for Individuals With Manifest Huntington Disease

    by Amy C. Ogilvie, Ryan M. Carnahan, Adys Mendizabal, Stephanie Gilbertson-White, Aaron T. Seaman, Elizabeth A. Chrischilles, Jordan L. Schultz

    There is a need to understand how different factors influence health care utilization for patients with Huntington disease (HD) to maximize benefits of primary and specialty care while minimizing need for costly emergency visits or hospitalizations. The primary objective of this study was to characterize how settings where patients with HD in Northern America receive care change throughout the disease course and determine whether the likelihood of different types of service utilization is influenced by clinical, sociodemographic, and caregiver characteristics. Data from the Enroll-HD study and joinpoint regression were used to assess trends in neurology visits, general practitioner visits, emergency department visits, and inpatient stays over the disease course and as a function of total functional capacity. Generalized estimating equation models were then used to identify factors associated with use of these different services in the 6 months before their study visit. Visits from 1,631 participants in the Northern America region from the Enroll-HD study were included in this study. Trends in neurology, emergency, and inpatient visits remained constant over most of the disease duration. For the general practitioner visits, there was an increasing trend in use throughout the course of disease. Clinical factors, such as psychiatric symptoms, functional ability, and comorbidities, were associated with use of multiple types of health care services. Sociodemographic and caregiver factors, such as race or ethnicity, urban or rural residence, and caregiver employment status, were also associated with use of multiple health care services. Clinical, sociodemographic, and caregiver-related factors were all associated with outpatient, emergent, and inpatient care. This work identifies multiple avenues for future research on how to improve access to and quality of care for patients with HD, specifically relating to reducing the need for emergency visits and inpatient stays and promoting collaboration among primary and specialty clinicians.


  • Open Access

    Evaluating GPT-4’s Semantic Understanding of Obstetric-based Healthcare Text through Nurse Ruth

    by Tia Pope, Stephanie Gilbertson-White, Ahmad Patooghy

    Nurse Ruth, an AI-driven assistant, is designed to support obstetric nursing in resource-limited environments and for non-specialist healthcare providers. To develop and validate Nurse Ruth, we introduced novel evaluation metrics—Semantic Transparency Metric (STM) and Semantic Understanding Metric (SUM)—to assess response accuracy, contextual relevance, and robustness against conventional and adversarial clinical queries. Through iterative refinement and targeted knowledge integration, Nurse Ruth surpassed the 80% threshold for STM and SUM, reinforcing its ability to provide clear, evidence-based, and contextually precise clinical guidance. While excelling in response clarity and contextual accuracy, further improvements are needed to enhance recall in complex, multi-domain obstetric scenarios. A comparative evaluation against leading AI models (GPT-4o, GPT-4, and GPT-o1) for semantic validation demonstrated Nurse Ruth’s superiority. It achieved 100% accuracy on obstetric challenge queries, outperforming general-purpose AI models in both precision and efficiency. Unlike these models, Nurse Ruth delivered concise, rapid responses, making it the most effective system for real-world clinical applications. These findings validate Nurse Ruth’s semantic understanding and establish a replicable framework for AI-driven decision support in specialized medical fields. Future work will focus on refining recall in multi-faceted obstetric cases and validating real-world clinical impact.


  • Symptom representations in people with multimorbidity undergoing treatment for cancer: a qualitative descriptive study

    by Sugandha Aggarwal, Nayung Youn, Alaa Albashayreh, Stephanie Gilbertson-White

    Purpose The symptom representations (i.e., beliefs and attitudes) that people with cancer hold about their symptom experience can impact how they self-manage their symptoms. Having two or more chronic conditions (multimorbidity) can complicate illness representations. Little is known about symptom representations in people with cancer and multimorbidity. Methods This qualitative descriptive study was conducted with a sample of adults with a diagnosis of cancer and at least one additional chronic condition. Semi-structured interviews were conducted to understand their symptom representations. Leventhal’s Common-Sense Model of Illness Representations (i.e., identity, consequences, cure/control, timeline, and cause) provided the guiding framework. A qualitative thematic analysis was used to identify codes, themes, and subthemes. Results The mean age of the participants (n = 17) was 62.1 years and primary cancer sites were gastrointestinal, thoracic, or head/neck. Five themes were identified: (1) perceiving and living with symptoms, (2) being unable to do things, (3) self-management behaviors, (4) domino theory, and (5) a side effect of conditions. These themes aligned with Leventhal’s Common-Sense Model dimensions. The interaction among diagnoses and multimorbidity was identified by a minority of participants. Conclusion People with cancer and multimorbidity described symptom representations primarily in the context of cancer. Consistent with previous research, symptoms negatively impacted their lives, and their representations include an understanding of how symptoms interact. Few participants described their symptoms within the larger context of multimorbidity. Future research is needed to determine how symptom representations impact their communication patterns with providers and coping behaviors.


  • Predictors of Concordance between Patient-Reported and Provider-Documented Symptoms in the Context of Cancer and Multimorbidity

    by Stephanie Gilbertson-White, Alaa Albashayreh, Yuwen Ji, Anindita Bandyopadhyay, Nahid Zeinali, Catherine Cherwin

    Background The integration of patient-reported outcomes (PROs) into clinical care, particularly in the context of cancer and multimorbidity, is crucial. While PROs have the potential to enhance patient-centered care and improve health outcomes through improved symptom assessment, they are not always adequately documented by the health care team. Objectives This study aimed to explore the concordance between patient-reported symptom occurrence and symptoms documented in electronic health records (EHRs) in people undergoing treatment for cancer in the context of multimorbidity. Methods We analyzed concordance between patient-reported symptom occurrence of 13 symptoms from the Memorial Symptom Assessment Scale and provider-documented symptoms extracted using NimbleMiner, a machine learning tool, from EHRs for 99 patients with various cancer diagnoses. Logistic regression guided with the Akaike Information Criterion was used to identify significant predictors of symptom concordance. Results Our findings revealed discrepancies in patient and provider reports, with itching showing the highest concordance (66%) and swelling showing the lowest concordance (40%). There was no statistically significant association between multimorbidity and high concordance, while lower concordance was observed for women, patients with advanced cancer stages, individuals with lower education levels, those who had partners, and patients undergoing highly emetogenic chemotherapy. Conclusion These results highlight the challenges in achieving accurate and complete symptom documentation in EHRs and the necessity for targeted interventions to improve the precision of clinical documentation. By addressing these gaps, health care providers can better understand and manage patient symptoms, ultimately contributing to more personalized and effective cancer care.


  • Open Access

    Leveraging oncology collaborative networks and biomedical informatics data resources to rapidly recruit and enroll rural residents into oncology quality of life clinical trials

    by Heath A. Davis, Asher A. Hoberg, Laura S. Jacobus, Kenneth Nepple, Aaron T. Seaman, Jamie Sorensen, George J. Weiner, Stephanie Gilbertson-White

    Purpose: This study assesses the feasibility of biomedical informatics resources for efficient recruitment of rural residents with cancer to a clinical trial of a quality-of-life (QOL) mobile app. These resources have the potential to reduce costly, time-consuming, in-person recruitment methods. Methods: A cohort was identified from the electronic health record data repository and cross-referenced with patients who consented to additional research contact. Rural–urban commuting area codes were computed to identify rurality. Potential participants were emailed study details, screening questions, and an e-consent link via REDCap. Consented individuals received baseline questionnaires automatically. A sample minimum of n = 80 [n = 40 care as usual (CAU) n = 40 mobile app intervention] was needed. Results: N = 1298 potential participants (n = 365 CAU; n = 833 intervention) were screened for eligibility. For CAU, 68 consented, 67 completed baseline questionnaires, and 54 completed follow-up questionnaires. For intervention, 100 consented, 97 completed baseline questionnaires, and 58 completed follow-up questionnaires. The CAU/intervention reached 82.5%/122.5% of the enrollment target within 2 days. Recruitment and retention rates were 15.3% and 57.5%, respectively. The mean age was 59.5 ± 13.5 years. The sample was 65% women, 20% racial/ethnic minority, and 35% resided in rural areas. Conclusion: These results demonstrate that biomedical informatics resources can be highly effective in recruiting for cancer QOL research. Precisely identifying individuals likely to meet inclusion criteria who previously indicated interest in research participation expedited recruitment. Participants completed the consent and baseline questionnaires with zero follow-up contacts from the research team. This low-touch, repeatable process may be highly effective for multisite clinical trials research seeking to include rural residents.


  • Natural Language Processing Accurately Differentiates Cancer Symptom Information in Electronic Health Record Narratives

    by Alaa Albashayreh, Anindita Bandyopadhyay, Nahid Zeinali, Min Zhang, Weiguo Fan, Stephanie Gilbertson White

    PURPOSE: Identifying cancer symptoms in electronic health record (EHR) narratives is feasible with natural language processing (NLP). However, more efficient NLP systems are needed to detect various symptoms and distinguish observed symptoms from negated symptoms and medication-related side effects. We evaluated the accuracy of NLP in (1) detecting 14 symptom groups (ie, pain, fatigue, swelling, depressed mood, anxiety, nausea/vomiting, pruritus, headache, shortness of breath, constipation, numbness/tingling, decreased appetite, impaired memory, disturbed sleep) and (2) distinguishing observed symptoms in EHR narratives among patients with cancer. METHODS: We extracted 902,508 notes for 11,784 unique patients diagnosed with cancer and developed a gold standard corpus of 1,112 notes labeled for presence or absence of 14 symptom groups. We trained an embeddings-augmented NLP system integrating human and machine intelligence and conventional machine learning algorithms. NLP metrics were calculated on a gold standard corpus subset for testing. RESULTS: The interannotator agreement for labeling the gold standard corpus was excellent at 92%. The embeddings-augmented NLP model achieved the best performance (F1 score = 0.877). The highest NLP accuracy was observed in pruritus (F1 score = 0.937) while the lowest accuracy was in swelling (F1 score = 0.787). After classifying the entire data set with embeddings-augmented NLP, we found that 41% of the notes included symptom documentation. Pain was the most documented symptom (29% of all notes) while impaired memory was the least documented (0.7% of all notes). CONCLUSION: We illustrated the feasibility of detecting 14 symptom groups in EHR narratives and showed that an embeddings-augmented NLP system outperforms conventional machine learning algorithms in detecting symptom information and differentiating observed symptoms from negated symptoms and medication-related side effects.


  • Open Access

    Using real-world electronic health record data to predict the development of 12 cancer-related symptoms in the context of multimorbidity

    by Anindita Bandyopadhyay, Alaa Albashayreh, Nahid Zeinali, Weiguo Fan, Stephanie Gilbertson-White

    Objective: This study uses electronic health record (EHR) data to predict 12 common cancer symptoms, assessing the efficacy of machine learning (ML) models in identifying symptom influencers.Materials and Methods: We analyzed EHR data of 8156 adults diagnosed with cancer who underwent cancer treatment from 2017 to 2020. Structured and unstructured EHR data were sourced from the Enterprise Data Warehouse for Research at the University of Iowa Hospital and Clinics. Several predictive models, including logistic regression, random forest (RF), and XGBoost, were employed to forecast symptom development. The performances of the models were evaluated by F1-score and area under the curve (AUC) on the testing set. The SHapley Additive exPlanations framework was used to interpret these models and identify the predictive risk factors associated with fatigue as an exemplar.Results: The RF model exhibited superior performance with a macro average AUC of 0.755 and an F1-score of 0.729 in predicting a range of cancer-related symptoms. For instance, the RF model achieved an AUC of 0.954 and an F1-score of 0.914 for pain prediction. Key predictive factors identified included clinical history, cancer characteristics, treatment modalities, and patient demographics depending on the symptom. For example, the odds ratio (OR) for fatigue was significantly influenced by allergy (OR = 2.3, 95% CI: 1.8-2.9) and colitis (OR = 1.9, 95% CI: 1.5-2.4).Discussion: Our research emphasizes the critical integration of multimorbidity and patient characteristics in modeling cancer symptoms, revealing the considerable influence of chronic conditions beyond cancer itself.Conclusion: We highlight the potential of ML for predicting cancer symptoms, suggesting a pathway for integrating such models into clinical systems to enhance personalized care and symptom management.